BSE filing, NSE: WSFIN. Summary written from the filing by ALFA Finder's alert engine.
WSFx Global Pay Ltd: key numbers
- Share price
- ₹63.30
- Market cap
- ₹77.67 Cr
- Revenue (annual)
- ₹107.9 Cr
- Net profit (annual)
- ₹6.14 Cr
- P/E (TTM)
- 11.3×Sector 19.1×
- Promoter holding
- 56.94%-0.06% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from WSFx Global Pay Ltd
All →WSFx Global Pay Earnings Call Transcript: Key Takeaways
WSFx delivered record Q2 turnover growth led by student remittances, despite macro headwinds in the US market. The pivot toward high-volume B2B channels is driving scale but compressing margins due to higher commission payouts.
WSFx Global Pay Investor Presentation: Key Takeaways
Q2 FY27 revenue from operations ₹44.58 Cr (+30.0% YoY), PBT ₹5.33 Cr (+9.6%), gross turnover ₹2,914 Cr (+41.2%). Perpetual AD-II licence received 30 July 2026.
WSFx Global Pay Employee Stock Options
WSFx Global Pay allotted 1,62,500 ESOPs to eligible employees under its 2018 scheme, effective 27 October 2026. Options vest in tranches through October 2029.
WSFx Global Pay Capacity Expansion
WSFx Global Pay's board approved opening a new branch office in Kanpur, Uttar Pradesh, expected on or before December 15, 2026. The branch is part of the company's regional business expansion.
- new branches
- 1.0 branches
WSFx Global Pay Q2 FY27 Results: Net Profit ₹4.3 Cr, Up 16.2% YoY
WSFx Global Pay Ltd reported revenue from operations of ₹44.6 Cr (+30.0% YoY) and net profit of ₹4.3 Cr (+16.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.3 Cr · +16.2% YoY
WSFx Global Pay Board Meeting Date
WSFx Global Pay Limited scheduled a Board meeting for October 26, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.